Timeline for EzriCare Artificial Tears, Delsam Pharma’s Artificial Tears, Delsam Pharma’s Artificial Eye Ointment
(Posted by Tom Lamb at Drug Injury Watch)
During February 2023 there were recalls of Global Pharma eye products, specifically:
- EzriCare Artificial Tears
- Delsam Pharma’s Artificial Tears
- Delsam Pharma’s Artificial Eye Ointment
Here is the most recent information from the US Centers for Disease Control and Prevention (CDC) about case reports associated with bacterial contamination of these Global Pharma eye products:
As of March 1, 2023, CDC, in partnership with state and local health departments, identified 64 patients in 13 states (CA, CO, CT, FL, IL, NJ, NM, NY, NV, TX, UT, WA, WI) with VIM-GES-CRPA, a rare strain of extensively drug-resistant P. aeruginosa. Thirty-seven patients were linked to four healthcare facility clusters. One person has died and there have been 8 reports of vision loss. Dates of specimen collection were from May 2022 to January 2023.
Source: CDC Healthcare-Associated Infections document "Outbreak of Extensively Drug-resistant Pseudomonas aeruginosa Associated with Artificial Tears" (accessed 3/1/23)
EzriCare Artificial Tears
Delsam Pharma’s Artificial Tears
Delsam Pharma’s Artificial Eye Ointment
Free Case Evaluation
Strictly Confidential, No Obligation.
- 2/1/2023: The CDC issued a warning about this Global Pharma eye product, EzriCare Artificial Tears, associated with serious eye infections in patients from various states during recent months.
- 2/2/2023: Global Pharma initiated a voluntary recall at the consumer level of all unexpired lots of EzriCare Artificial Tears as well as a second Global Pharma eye product, Delsam Pharma’s Artificial Tears.
- 2/21/2023: First announcement by the FDA about Delsam Pharma’s Artificial Eye Ointment is a warning not to purchase or use this different type of Global Pharma eye product.
- 2/22/2023: Second announcement by the FDA, one day later, is about a Delsam Pharma’s Artificial Eye Ointment recall by Global Pharma.
For more information, see our earlier articles about this bacterial contamination problem for these three Global Pharma eye products, EzriCare Artificial Tears, EzriCare Artificial Tears, and Delsam Pharma's Artificial Eye Ointment:
- "EzriCare Artificial Tears Associated With Eye Infections: February 2023 CDC Warnings Issued" (2/2/23)
- "Artificial Tears Eye Drops Recall Involving EzriCare and Delsam Pharma's Products in February 2023" (2/7/23)
- "Delsam Pharma's Artificial Eye Ointment Recalled, Weeks After Artificial Tears Products Withdrawal" (2/22/23)
We are investigating cases involving hospitalization, death, or permanent vision loss from an infection due to the use of these Global Pharma eye products: (1) Delsam Pharma’s Artificial Eye Ointment; (2) Delsam Pharma’s Artificial Tears; or, (3) EzriCare Artificial Tears.
These cases are possible drug injury lawsuits that would be filed against Global Pharma.
Let us know if we can be of assistance to you or someone you know by submitting an online Case Evaluation Form or calling us at 800-426-9535.
DrugInjuryLaw.com: Medical & Legal Information About Drug Side Effects (All website content by attorney Tom Lamb)
Drug Injury Case Evaluation - Free. Confidential. No Obligation. (Case review is done by attorney Tom Lamb)